PACS Group, Inc.

PACS Healthcare Medical Care Facilities

PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.

Revenue
+11.5%
EPS
+16.4%
Free cash flow
−4.31%
Total debt
+7.48%

Quarter to September 2026, against a year earlier

50.09 0.17 −0.34%
Market cap
$8.0B
P/E
28.6×
Fwd P/E
21.8×
Dividend yield
—
F-score
7/9
Altman Z
2.00
Beneish M
−2.74
Dividend safety
n/a

Revenue by segment Fiscal 2025

  • Reportable Segment

Every year since 2022 →

Insider Decisions last twelve months

Sold, $m 116.11
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — 1 — 1 4 5 4 5 9 3
Insider Ownership 71.26%

Capital & Financial Ratios $m

Size
Market Cap 7,970.00
Revenue ttm 5,705.05
Net income ttm 277.61
Free cash flow ttm 448.48
Net debt Q 157.05
Valuation
P/E 28.56
Forward P/E 21.80
Price / sales 1.39
Forward P/S Powerpack
Price / FCF 17.69
Price / book 6.51 (above 6: high)
Financial health
Current ratio Q 0.80 (below 1: weak)
Debt / equity Q 0.22 (at or below 0.5: strong)
Interest coverage Q 19.56
Growth
Revenue growth Q +11.45% (above 0%: growing)
Operating income growth Q +15.59% (above 0%: growing)
EPS, this year +30.92% (at or above 15%: strong)
EPS, next year A +12.27%
Revenue, next year A +10.63% (at or above 10%: strong)
EPS, past 5 yrs —
EPS, next 5 yrs A +17.90% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 73 158 197 115
Receivables 600 717 702 750
Inventory — — — —
Other — — — —
722 938 1,070 947
2023 2024 2025 Q'26
Payables 141 175 192 177
ST’ Debt 17 15 4 8
Other — 146 181 181
457 978 1,001 1,182

Compound Annual Growth %

10y 5y 3y
Sales — — 29.74%
Cash Flow — — 63.42%
Earnings — — 8.37%
Book Value — — 140.29%

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 0.50 0.47 0.37 — —
’25 0.17 0.31 0.32 0.43 1.22
’24 0.27 (0.21) 0.10 0.25 0.38
’23 0.29 0.16 0.15 0.27 0.88
’22 — — — — 1.17
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 1,420 1,428 1,499 — —
’25 1,277 1,309 1,345 1,358 5,289
’24 920 936 1,026 1,208 4,090
’23 708 761 789 853 3,111
’22 — — — — 2,422
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 236 136 211 — —
’25 150 53 205 (3) 404
’24 59 35 209 65 367
’23 79 (21) 15 (10) 64
’22 — — — 93 93
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 215 109 179 — —
’25 133 34 187 (54) 300
’24 48 19 195 40 302
’23 73 (31) 1 (25) 19
’22 — — — 70 70
Fiscal quarters ending in the months shown.

Valuation

The price implies free cash flow after share-based pay growing 8.1% a year for ten years.

Implied
8.1%
Open the model

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue — — — — — 1,167 2,422 3,111 4,090 5,289 5,705 +45.9% 5,851 6,544 7,127 +10.5%
Gross margin, % — — — — — 16.06 16.54 14.37 12.41 14.75 17.11 (1.3) pt
EBT — — — — — 81 207 157 102 284 398 +36.7%
EBT margin, % — — — — — 6.98 8.55 5.06 2.48 5.38 6.97 (1.6) pt
Net income — — — — — 48 150 113 55 191 278 +41.4%
Per share, $
Per share, $ Revenue — — — — — 9.06 18.82 24.17 27.89 33.86 36.02 +39.0%
Earnings — — — — — 0.37 1.17 0.88 0.38 1.23 1.75 +34.8%
Cash flow — — — — — 0.45 0.72 0.49 2.50 2.59 3.66 +55.1%
Capex — — — — — (0.96) (0.18) (0.35) (0.44) (0.67) (0.83) (8.7%)
Free cash flow — — — — — (0.52) 0.54 0.15 2.06 1.92 2.83 n/m
Book value — — — — — 0.00 0.53 0.79 4.88 6.10 7.70 n/m
Shares, m — — — — — 129 129 129 147 156 157 +5.0%
Valuation, ×
Valuation, × P/E — — — — — 26.89 26.89 26.89 32.20 31.47 28.56 28.9
P/S — — — — — 0.89 0.89 0.89 0.47 1.13 1.39 0.9
P/B — — — — — 22.16 22.16 22.16 2.69 6.30 6.51 15.1
EV/Sales — — — — — 1.10 1.10 1.10 0.50 1.16 1.42 1.0
EV/FCF — — — — — (546.96) (546.96) (546.96) 6.72 20.52 18.04 (322.7)
Cash, $m
Cash, $m Operating cash flow — — — — — 58 93 64 367 404 580 +62.8%
Capex — — — — — (124) (23) (45) (65) (105) (131) (4.2%)
Free cash flow — — — — — (66) 70 19 302 300 448 n/m
Balance, $m
Balance, $m Working capital — — — — — — 27 265 (40) 68 (236) +35.8%
Net debt — — — — — — 441 659 108 152 157 (29.9%)
Shareholders’ equity — — — — — — 69 102 716 952 1,219 +140.3%
Returns, %
Returns, % ROA — — — — — 0.00 12.23 3.78 1.27 3.54 4.81 +3.5 pt
ROIC — — — — — 0.00 28.10 17.07 9.34 17.52 19.25 +17.5 pt
ROE — — — — — 0.00 0.00 132.50 13.64 22.96 26.49 +23.0 pt
People
People Employees — — — — — — — 32,433 45,680 47,455 — +21.0%
Revenue/emp, $m — — — — — 0.00 0.00 0.10 0.09 0.11 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026

Business profile

Updated

PACS Group is a post-acute healthcare company focused on skilled nursing care. Its facilities serve people who need nursing and other inpatient services after a hospital stay, as well as people who need longer-term custodial care. Some communities also offer senior care, assisted living and independent living.

Skilled nursing facilities sit between hospitals and lower-acuity settings such as assisted living or care at home. They can provide around-the-clock inpatient services to patients recovering from illnesses, acute conditions or medical procedures. PACS primarily focuses on short-term transitional care for patients with more complex needs.

Where the money comes from and where it goes Fiscal 2025

Fiscal 2025: revenue by segment, and margins
Reportable Segment 5,289 100.00%
Gross margin 14.75%
Operating margin 5.85%
Pre-tax margin 5.38%

Revenue by segment since 2022

PACS Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
FMS Fresenius Medical Care AG & Co. KGaA $12.6B 12.6× 14.4× −0.49% (below 0%: shrinking) −10.55% (below 0%: shrinking) −3.47% (below 0%: shrinking) 25.83% 7.78% Compare
DVA DaVita Inc. $12.3B 14.0× 13.0× +4.62% (above 0%: growing) +66.99% (above 0%: growing) −45.83% (below 0%: shrinking) 31.50% 13.95% Compare
UHS Universal Health Services, Inc. $11.7B 8.2× 8.0× +5.30% (above 0%: growing) −9.98% (below 0%: shrinking) +216.74% (above 0%: growing) 90.99% 9.60% Compare
ENSG The Ensign Group, Inc. $10.6B 26.3× 25.4× +14.47% (above 0%: growing) +23.64% (above 0%: growing) +89.21% (above 0%: growing) 16.86% 9.30% Compare
PACS PACS Group, Inc. $8.0B 28.6× 21.8× +11.45% (above 0%: growing) +16.36% (above 0%: growing) −4.31% (below 0%: shrinking) 17.23% 6.65%
CHE Chemed Corporation $7.0B 25.5× 24.0× +10.57% (above 0%: growing) +23.09% (above 0%: growing) −45.25% (below 0%: shrinking) 33.72% 13.96% Compare
CON Concentra Group Holdings Parent, Inc. $5.4B 24.9× 25.2× +8.61% (above 0%: growing) +36.84% (above 0%: growing) −19.76% (below 0%: shrinking) 31.42% 18.52% Compare
LFST LifeStance Health Group, Inc. $5.1B 70.7× 81.1× +25.30% (above 0%: growing) +2,042.86% (above 0%: growing) +31.57% (above 0%: growing) 0.00% 7.26% Compare
OPCH Option Care Health, Inc. $4.7B 22.6× 21.2× +4.08% (above 0%: growing) +19.81% (above 0%: growing) −17.04% (below 0%: shrinking) 19.08% 5.97% Compare
Median of peers $8.8B 23.8× 22.6× +6.96% +23.37% −10.25% 28.63% 9.45%

All 51 Medical Care Facilities stocks →

From the latest earnings call

Updated

  • CEO Jason Murray said the existing portfolio drove the quarter’s performance, with higher occupancy and skilled mix contributing to margin improvement as facilities mature.
  • CFO Carey Hendrickson said the raised annual outlook includes a modest contribution from newly acquired Texas facilities but excludes pending acquisitions and uncertain supplemental payments.

Largest institutional holders 13F, quarter to 30 June 2026

Held by institutions 31.27%
Held by the ten largest 22.30%
Holder Shares Stake Change
COHEN & STEERS, INC. 8.34m 5.27% −779.75k
Fidelity (FMR) 6.21m 3.92% +959.48k
Vanguard 4.22m 2.67% +180.82k
BlackRock 4.16m 2.62% +380.12k
Crewe Advisors LLC 3.31m 2.09% +553.01k
American Century 3.11m 1.96% +1.30m
Ameriprise (Columbia Threadneedle) 2.00m 1.26% +873.73k
Alyeska Investment Group, L.P. 1.54m 0.97% −1.46m
Dimensional Fund Advisors 1.23m 0.78% +450.57k
Geode Capital Management 1.21m 0.76% +94.93k
13F filings for the quarter to 30 June 2026: long positions in US-listed shares reported by managers with $100m or more, ~45 days after the quarter.

Pay and ownership Proxy statement filed 28 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 17.07m 17.97m 167.00
2024 5.04m 5.04m 57.00
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Read the proxy statement

PACS Group, Inc. (PACS) Latest News

3 Nov

Impact 4 · · Business Wire

7 Oct

21 Sep

Impact 3 · · Business Wire

19 Aug

Impact 3 · · MarketBeat

11 Aug

Impact 4 · · The Motley Fool transcript

8 Aug

Impact 4 · · MarketBeat transcript

PACS metrics, ten years each

stockrow.com/PACS · Data as of Nov 5, 2026 · For information only; not investment advice. · © 2026 stockrow.com